Liang, H., Lin, G., Wang, W., Huang, J., Yang, Y., Lan, Y., . . . Liang, W. (2020). Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: A Bayesian network meta-analysis. Transl Lung Cancer Res.
Citação norma ChicagoLiang, Hengrui, et al. "Feasibility and Safety of PD-1/L1 Inhibitors for Non-small Cell Lung Cancer in Front-line Treatment: A Bayesian Network Meta-analysis." Transl Lung Cancer Res 2020.
Citação norma MLALiang, Hengrui, et al. "Feasibility and Safety of PD-1/L1 Inhibitors for Non-small Cell Lung Cancer in Front-line Treatment: A Bayesian Network Meta-analysis." Transl Lung Cancer Res 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.